{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:31:52Z","timestamp":1793082712147,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"crossref","award":["D43TW012487"],"award-info":[{"award-number":["D43TW012487"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-10481-w","type":"journal-article","created":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T09:43:06Z","timestamp":1740822186000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Antimicrobial resistance of bacterial pathogens isolated from cancer patients: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Onyansaniba K.","family":"Ntim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Awere-Duodu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul-Halim","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S.","family":"Donkor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,1]]},"reference":[{"key":"10481_CR1","doi-asserted-by":"publisher","first-page":"415","DOI":"10.2147\/IDR.S287792","volume":"14","author":"IA Dutescu","year":"2021","unstructured":"Dutescu IA, Hillier SA. Encouraging the development of New antibiotics: are Financial Incentives the Right Way Forward? A systematic review and case study. Infect Drug Resist. 2021;14:415\u201334.","journal-title":"Infect Drug Resist"},{"key":"10481_CR2","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"CJL Murray","year":"2022","unstructured":"Murray CJL, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629\u201355.","journal-title":"Lancet"},{"key":"10481_CR3","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.3390\/healthcare11131946","volume":"11","author":"MA Salam","year":"2023","unstructured":"Salam MA, et al. Antimicrobial Resistance: a growing serious threat for Global Public Health. Healthcare. 2023;11:1946.","journal-title":"Healthcare"},{"key":"10481_CR4","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3390\/antibiotics13070662","volume":"13","author":"ES Donkor","year":"2024","unstructured":"Donkor ES, Odoom A, Osman A-H, Darkwah S, Kotey FC. N. A systematic review on Antimicrobial Resistance in Ghana from a one health perspective. Antibiotics. 2024;13:662.","journal-title":"Antibiotics"},{"key":"10481_CR5","doi-asserted-by":"publisher","first-page":"849","DOI":"10.2147\/IDR.S289741","volume":"14","author":"E Giacomini","year":"2021","unstructured":"Giacomini E, et al. Evidence of Antibiotic Resistance from Population-Based studies: a narrative review. Infect Drug Resist. 2021;14:849\u201358.","journal-title":"Infect Drug Resist"},{"key":"10481_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"10481_CR7","unstructured":"World Health Organization. Global cancer burden growing, amidst mounting need for services. https:\/\/www.who.int\/news\/item\/01-02-2024-global-cancer-burden-growing--amidst-mounting-need-for-services (2024)."},{"key":"10481_CR8","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3322\/caac.21697","volume":"71","author":"AK Nanayakkara","year":"2021","unstructured":"Nanayakkara AK, et al. Antibiotic resistance in the patient with cancer: escalating challenges and paths forward. CA Cancer J Clin. 2021;71:488\u2013504.","journal-title":"CA Cancer J Clin"},{"key":"10481_CR9","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s40121-021-00433-7","volume":"10","author":"Y Zheng","year":"2021","unstructured":"Zheng Y, et al. Fatal infections among Cancer patients: a Population-based study in the United States. Infect Dis Ther. 2021;10:871.","journal-title":"Infect Dis Ther"},{"key":"10481_CR10","first-page":"329","volume":"13","author":"I Kourbeti","year":"2024","unstructured":"Kourbeti I, Kamiliou A, Samarkos M. Antibiotic stewardship in Surgical Departments. Antibiot Basel Switz. 2024;13:329.","journal-title":"Antibiot Basel Switz"},{"key":"10481_CR11","doi-asserted-by":"publisher","first-page":"e0255107","DOI":"10.1371\/journal.pone.0255107","volume":"16","author":"M Tew","year":"2021","unstructured":"Tew M, et al. Excess cost of care associated with sepsis in cancer patients: results from a population-based case-control matched cohort. PLoS ONE. 2021;16:e0255107.","journal-title":"PLoS ONE"},{"key":"10481_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ijid.2014.12.022","volume":"31","author":"P Cornejo-Ju\u00e1rez","year":"2015","unstructured":"Cornejo-Ju\u00e1rez P, et al. The impact of hospital-acquired infections with multidrug-resistant bacteria in an oncology intensive care unit. Int J Infect Dis. 2015;31:31\u20134.","journal-title":"Int J Infect Dis"},{"key":"10481_CR13","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1007\/s00277-018-3423-5","volume":"97","author":"S Scheich","year":"2018","unstructured":"Scheich S, et al. Bloodstream infections with gram-negative organisms and the impact of multidrug resistance in patients with hematological malignancies. Ann Hematol. 2018;97:2225\u201334.","journal-title":"Ann Hematol"},{"key":"10481_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12879-023-08182-3","volume":"23","author":"AS Danielsen","year":"2023","unstructured":"Danielsen AS, et al. Clinical outcomes of antimicrobial resistance in cancer patients: a systematic review of multivariable models. BMC Infect Dis. 2023;23:247.","journal-title":"BMC Infect Dis"},{"key":"10481_CR15","doi-asserted-by":"publisher","first-page":"n160","DOI":"10.1136\/bmj.n160","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160.","journal-title":"BMJ"},{"key":"10481_CR16","doi-asserted-by":"publisher","first-page":"e1771","DOI":"10.1002\/wnan.1771","volume":"14","author":"A Basu","year":"2022","unstructured":"Basu A, Singh R, Gupta S. Bacterial infections in cancer: a bilateral relationship. WIREs Nanomed Nanobiotechnol. 2022;14:e1771.","journal-title":"WIREs Nanomed Nanobiotechnol"},{"key":"10481_CR17","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1097\/01.TP.0000120181.89206.54","volume":"77","author":"M Guba","year":"2004","unstructured":"Guba M, Graeb C, Jauch K-W, Geissler EK. Pro- and anti-cancer effects of Immunosuppressive agents used in Organ Transplantation. Transplantation. 2004;77:1777.","journal-title":"Transplantation"},{"key":"10481_CR18","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1681\/ASN.V1061366","volume":"10","author":"JF Gummert","year":"1999","unstructured":"Gummert JF, Ikonen T, Morris RE. Newer immunosuppressive drugs: a review. J Am Soc Nephrol. 1999;10:1366\u201380.","journal-title":"J Am Soc Nephrol"},{"key":"10481_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/lam.12436","volume":"61","author":"S Wong","year":"2015","unstructured":"Wong S, Slavcev RA. Treating cancer with infection: a review on bacterial cancer therapy. Lett Appl Microbiol. 2015;61:107\u201312.","journal-title":"Lett Appl Microbiol"},{"key":"10481_CR20","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1586\/14787210.2014.920253","volume":"12","author":"C Gudiol","year":"2014","unstructured":"Gudiol C, Carratal\u00e0 J. Antibiotic resistance in cancer patients. Expert Rev Anti Infect Ther. 2014;12:1003\u201316.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10481_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1634\/theoncologist.2019-0160","volume":"25","author":"N Tinsley","year":"2020","unstructured":"Tinsley N, et al. Cumulative antibiotic use significantly decreases efficacy of checkpoint inhibitors in patients with Advanced Cancer. Oncologist. 2020;25:55\u201363.","journal-title":"Oncologist"},{"key":"10481_CR22","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1080\/08923973.2022.2145966","volume":"45","author":"J Yu","year":"2023","unstructured":"Yu J, et al. Effect of concomitant antibiotics use on patient outcomes and adverse effects in patients treated with ICIs. Immunopharmacol Immunotoxicol. 2023;45:386\u201394.","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10481_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0213-005X(13)70126-5","volume":"31","author":"R Cant\u00f3n","year":"2013","unstructured":"Cant\u00f3n R, Horcajada JP, Oliver A, Garbajosa PR, Vila J. Inappropriate use of antibiotics in hospitals: the complex relationship between antibiotic use and antimicrobial resistance. Enferm Infecc Microbiol Clin. 2013;31:3\u201311.","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10481_CR24","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/j.1574-6976.2011.00295.x","volume":"35","author":"R Cant\u00f3n","year":"2011","unstructured":"Cant\u00f3n R, Morosini M-I. Emergence and spread of antibiotic resistance following exposure to antibiotics. FEMS Microbiol Rev. 2011;35:977\u201391.","journal-title":"FEMS Microbiol Rev"},{"key":"10481_CR25","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.jcrc.2013.04.008","volume":"28","author":"C Hui","year":"2013","unstructured":"Hui C, Lin M-C, Jao M-S, Liu T-C, Wu R-G. Previous antibiotic exposure and evolution of antibiotic resistance in mechanically ventilated patients with nosocomial infections. J Crit Care. 2013;28:728\u201334.","journal-title":"J Crit Care"},{"key":"10481_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/978-3-319-04220-6_2","volume":"161","author":"TR Zembower","year":"2014","unstructured":"Zembower TR. Epidemiology of infections in Cancer patients. Infect Complicat Cancer Patients. 2014;161:43\u201389.","journal-title":"Infect Complicat Cancer Patients"},{"key":"10481_CR27","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3390\/ph15040476","volume":"15","author":"S Alfei","year":"2022","unstructured":"Alfei S, Schito AM. \u03b2-Lactam antibiotics and \u03b2-Lactamase enzymes inhibitors, part 2: our Limited resources. Pharmaceuticals. 2022;15:476.","journal-title":"Pharmaceuticals"},{"key":"10481_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4236\/aim.2021.111004","volume":"11","author":"K Nagshetty","year":"2021","unstructured":"Nagshetty K, Shilpa BM, Patil SA, Shivannavar CT, Manjula NG. An overview of Extended Spectrum Beta lactamases and Metallo Beta Lactamases. Adv Microbiol. 2021;11:37.","journal-title":"Adv Microbiol"},{"key":"10481_CR29","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3390\/antibiotics13070659","volume":"13","author":"L Gahimbare","year":"2024","unstructured":"Gahimbare L, et al. Antimicrobial Resistance in the WHO African Region: a systematic literature review 2016\u20132020. Antibiotics. 2024;13:659.","journal-title":"Antibiotics"},{"key":"10481_CR30","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s12038-021-00209-8","volume":"46","author":"SS Mohapatra","year":"2021","unstructured":"Mohapatra SS, Dwibedy SK, Padhy I. Polymyxins, the last-resort antibiotics: Mode of action, resistance emergence, and potential solutions. J Biosci. 2021;46:85.","journal-title":"J Biosci"},{"key":"10481_CR31","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2147\/IDR.S147459","volume":"10","author":"EI Kritsotakis","year":"2017","unstructured":"Kritsotakis EI, et al. Prevalence, incidence burden, and clinical impact of healthcare-associated infections and antimicrobial resistance: a national prevalent cohort study in acute care hospitals in Greece. Infect Drug Resist. 2017;10:317\u201328.","journal-title":"Infect Drug Resist"},{"key":"10481_CR32","doi-asserted-by":"publisher","first-page":"117863022412432","DOI":"10.1177\/11786302241243239","volume":"18","author":"A-H Osman","year":"2024","unstructured":"Osman A-H, et al. Reservoirs of Nosocomial pathogens in Intensive Care units: a systematic review. Environ Health Insights. 2024;18:11786302241243239.","journal-title":"Environ Health Insights"},{"key":"10481_CR33","first-page":"277","volume":"40","author":"CL Ventola","year":"2015","unstructured":"Ventola CL. The Antibiotic Resistance Crisis. Pharm Ther. 2015;40:277\u201383.","journal-title":"Pharm Ther"},{"key":"10481_CR34","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1093\/jac\/dku174","volume":"69","author":"D Nurjadi","year":"2014","unstructured":"Nurjadi D, et al. Emergence of trimethoprim resistance gene dfrG in Staphylococcus aureus causing human infection and colonization in sub-saharan Africa and its import to Europe. J Antimicrob Chemother. 2014;69:2361\u20138.","journal-title":"J Antimicrob Chemother"},{"key":"10481_CR35","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3390\/pathogens10030373","volume":"10","author":"I Kyriakidis","year":"2021","unstructured":"Kyriakidis I, Vasileiou E, Pana ZD, Tragiannidis A. Acinetobacter baumannii Antibiotic Resistance mechanisms. Pathogens. 2021;10:373.","journal-title":"Pathogens"},{"key":"10481_CR36","doi-asserted-by":"crossref","unstructured":"Lee C-R et al. Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance mechanisms, and prospective treatment options. Front Cell Infect Microbiol 7, (2017).","DOI":"10.3389\/fcimb.2017.00055"},{"key":"10481_CR37","doi-asserted-by":"publisher","first-page":"h6420","DOI":"10.1136\/bmj.h6420","volume":"352","author":"J Iredell","year":"2016","unstructured":"Iredell J, Brown J, Tagg K. Antibiotic resistance in Enterobacteriaceae: mechanisms and clinical implications. BMJ. 2016;352:h6420.","journal-title":"BMJ"},{"key":"10481_CR38","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s10096-013-1819-7","volume":"32","author":"E Montassier","year":"2013","unstructured":"Montassier E, Batard E, Gastinne T, Potel G, de La Cocheti\u00e8re MF. Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance. Eur J Clin Microbiol Infect Dis. 2013;32:841\u201350.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10481_CR39","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.tmaid.2018.05.016","volume":"24","author":"M van Aalst","year":"2018","unstructured":"van Aalst M, et al. Incidence of invasive pneumococcal disease in immunocompromised patients: a systematic review and meta-analysis. Travel Med Infect Dis. 2018;24:89\u2013100.","journal-title":"Travel Med Infect Dis"},{"key":"10481_CR40","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.cmi.2021.03.026","volume":"27","author":"ID Olaru","year":"2021","unstructured":"Olaru ID, et al. The association between antimicrobial resistance and HIV infection: a systematic review and meta-analysis. Clin Microbiol Infect. 2021;27:846\u201353.","journal-title":"Clin Microbiol Infect"},{"key":"10481_CR41","doi-asserted-by":"crossref","unstructured":"Jacobs MR. Drug-resistant Streptococcus pneumoniae: rational antibiotic choices. Am J Med 106, 19S-25S; discussion 48S-52S (1999).","DOI":"10.1016\/S0002-9343(98)00351-9"},{"key":"10481_CR42","doi-asserted-by":"publisher","first-page":"421","DOI":"10.4161\/viru.21282","volume":"3","author":"BL Hollenbeck","year":"2012","unstructured":"Hollenbeck BL, Rice LB. Intrinsic and acquired resistance mechanisms in enterococcus. Virulence. 2012;3:421\u2013569.","journal-title":"Virulence"},{"key":"10481_CR43","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1128\/aem.61.1.374-376.1995","volume":"61","author":"EW Rice","year":"1995","unstructured":"Rice EW, Messer JW, Johnson CH, Reasoner DJ. Occurrence of high-level aminoglycoside resistance in environmental isolates of enterococci. Appl Environ Microbiol. 1995;61:374\u20136.","journal-title":"Appl Environ Microbiol"},{"key":"10481_CR44","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/978-3-030-80108-3_17","volume-title":"Innovations in Biotechnology for a sustainable future","author":"A Musini","year":"2021","unstructured":"Musini A, Kandula P, Giri A. Drug resistance mechanism in Staphylococcus aureus. In: Maddela NR, Garc\u00eda LC, editors. Innovations in Biotechnology for a sustainable future. Cham: Springer International Publishing; 2021. pp. 355\u201376. https:\/\/doi.org\/10.1007\/978-3-030-80108-3_17."},{"key":"10481_CR45","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2217\/17460913.2.3.323","volume":"2","author":"A Pantosti","year":"2007","unstructured":"Pantosti A, Sanchini A, Monaco M. Mechanisms of antibiotic resistance in Staphylococcus aureus. Future Microbiol. 2007;2:323\u201334.","journal-title":"Future Microbiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10481-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-10481-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10481-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T10:22:21Z","timestamp":1740824541000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-10481-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10481"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-10481-w","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,1]]},"assertion":[{"value":"21 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"296"}}